Evidence map›Paper›PMID 37149405›Full record

ReviewTrends in immunology2023

The RNA polymerase III-RIG-I axis in antiviral immunity and inflammation.

Leslie Naesens, Filomeen Haerynck, Michaela U Gack

Open access · bronzeAbstract readReview
In one paragraph

Review in Trends in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 26 citations in OpenAlex.

  1. YBX1 regulates RNA polymerase III transcripts to prevent inflammation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Role of E5 from HPV16 in the Evasion of the Immune Response.International journal of molecular sciences · 2026
    Review
  5. Article
  6. Article
  7. Y-box binding proteins in immunity and RNA virus infection.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. MDA5 ISGylation is crucial for immune signaling to control viral replication and pathogenesis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Leslie NaesensDepartment of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium; Primary Immunodeficiency Research Lab, Center for Primary Immunodeficiency, Jeffrey Modell Diagnosis and Research Center, Ghent University Hospital, Ghent, Belgium.
Filomeen HaerynckDepartment of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium; Primary Immunodeficiency Research Lab, Center for Primary Immunodeficiency, Jeffrey Modell Diagnosis and Research Center, Ghent University Hospital, Ghent, Belgium.
Michaela U GackFlorida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, FL, USA. Electronic address: gackm@ccf.org.
Ghent University Hospital · BECleveland Clinic Florida · US

Funding

Defining the viral PTMome: Towards the development of novel antiviral approachesDP1AI169444 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI GACK, MICHAELA ULRIKE · 2021 to 2025
$5.6M
Regulation of Host Innate Immunity Against Viral InfectionR01AI087846 · NIAID · UNIVERSITY OF CHICAGO · PI GACK, MICHAELA ULRIKE · 2010 to 2020
$3.9M
Regulation of Host Innate Immunity Against Viral InfectionR37AI087846 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI Michaela Ulrike Gack · 2021 to 2026
$2.8M
Novel Role for Host Immunostimulatory RNA in Antiviral Immune DefenseR01AI165502 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI GACK, MICHAELA ULRIKE · 2021 to 2025
$2.3M
The Role of TRIM23 in Autophagy Mediated Antiviral DefensesR01AI148534 · NIAID · UNIVERSITY OF CHICAGO · PI GACK, MICHAELA ULRIKE · 2020 to 2024
$2.3M
NIAID NIH HHS DP1 AI169444NIAID NIH HHS R01 AI087846NIAID NIH HHS R01 AI148534NIAID NIH HHS R01 AI165502NIAID NIH HHS R37 AI087846
6 · The paper itself

Abstract

Nucleic acid sensors survey subcellular compartments for atypical or mislocalized RNA or DNA, ultimately triggering innate immune responses. Retinoic acid-inducible gene-I (RIG-I) is part of the family of cytoplasmic RNA receptors that can detect viruses. A growing literature demonstrates that mammalian RNA polymerase III (Pol III) transcribes certain viral or cellular DNA sequences into immunostimulatory RIG-I ligands, which elicits antiviral or inflammatory responses. Dysregulation of the Pol III-RIG-I sensing axis can lead to human diseases including severe viral infection outcomes, autoimmunity, and tumor progression. Here, we summarize the newly emerging role of viral and host-derived Pol III transcripts in immunity and also highlight recent advances in understanding how mammalian cells prevent unwanted immune activation by these RNAs to maintain homeostasis.

Indexed as

RNA Polymerase IIIAnimalsDEAD Box Protein 58HumansImmunity, InnateInflammationMammalsRNARNA, ViralDEAD Box Protein 58RNARNA Polymerase IIIRNA, Viralantiviral immunitycancerinflammationRIG-IRNA polymerase III

Identifiers

PMID37149405
PMCPMC10461603
OpenAlexW4368341906

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.